BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29674173)

  • 1. Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer.
    McKenna MT; Weis JA; Brock A; Quaranta V; Yankeelov TE
    Transl Oncol; 2018 Jun; 11(3):732-742. PubMed ID: 29674173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Drug Resistance in Breast Cancer with Mathematical Oncology.
    Brocato T; Dogra P; Koay EJ; Day A; Chuang YL; Wang Z; Cristini V
    Curr Breast Cancer Rep; 2014 Jun; 6(2):110-120. PubMed ID: 24891927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of Nanomedicine in Tumor Spheroid as an
    Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
    Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational oncology--mathematical modelling of drug regimens for precision medicine.
    Barbolosi D; Ciccolini J; Lacarelle B; Barlési F; André N
    Nat Rev Clin Oncol; 2016 Apr; 13(4):242-54. PubMed ID: 26598946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
    Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
    Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current problems in surgical oncology: 1. Theoretical models in oncology and their implications in surgical therapy].
    Vasilescu C
    Chirurgia (Bucur); 2011; 106(1):17-22. PubMed ID: 21523955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From patient-specific mathematical neuro-oncology to precision medicine.
    Baldock AL; Rockne RC; Boone AD; Neal ML; Hawkins-Daarud A; Corwin DM; Bridge CA; Guyman LA; Trister AD; Mrugala MM; Rockhill JK; Swanson KR
    Front Oncol; 2013; 3():62. PubMed ID: 23565501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical models for translational and clinical oncology.
    Gallasch R; Efremova M; Charoentong P; Hackl H; Trajanoski Z
    J Clin Bioinforma; 2013 Nov; 3(1):23. PubMed ID: 24195863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues.
    Kim M; Gillies RJ; Rejniak KA
    Front Oncol; 2013 Nov; 3():278. PubMed ID: 24303366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-tech in radiation oncology: should there be a ceiling?
    Bentzen SM
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):320-30. PubMed ID: 14751499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging Mathematical Modeling to Quantify Pharmacokinetic and Pharmacodynamic Pathways: Equivalent Dose Metric.
    McKenna MT; Weis JA; Quaranta V; Yankeelov TE
    Front Physiol; 2019; 10():616. PubMed ID: 31178753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illuminating the Numbers: Integrating Mathematical Models to Optimize Photomedicine Dosimetry and Combination Therapies.
    Spring BQ; Lang RT; Kercher EM; Rizvi I; Wenham RM; Conejo-Garcia JR; Hasan T; Gatenby RA; Enderling H
    Front Phys; 2019 Apr; 7():. PubMed ID: 31123672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmenting Surgery via Multi-scale Modeling and Translational Systems Biology in the Era of Precision Medicine: A Multidisciplinary Perspective.
    Kassab GS; An G; Sander EA; Miga MI; Guccione JM; Ji S; Vodovotz Y
    Ann Biomed Eng; 2016 Sep; 44(9):2611-25. PubMed ID: 27015816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated PK-PD and agent-based modeling in oncology.
    Wang Z; Butner JD; Cristini V; Deisboeck TS
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):179-89. PubMed ID: 25588379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
    K W To K; Cho WCS
    Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.